Teva Pharmaceutical Industries Newsroom

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJun 27 11:38 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJun 5 11:20 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMay 30 11:47 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMay 13 08:47 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMay 9 11:42 ET

Teva Upgraded at J.P. Morgan on Upcoming Catalysts

Seeking AlphaMar 8 10:24 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMar 8 08:12 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaFeb 12 05:27 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaFeb 5 08:45 ET

UBS Remains a Buy on Teva Pharmaceutical (TEVA)

TipRanksFeb 1 04:25 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJan 29 07:03 ET

Barclays Remains a Buy on Teva Pharmaceutical (TEVA)

TipRanksJan 29 05:07 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJan 23 05:53 ET

BofA Securities Adjusts Teva Pharmaceutical Industries Price Target to $14 From $13, Maintains Buy Rating

MT NewswiresJan 12 10:00 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJan 3 04:43 ET

HSBC Initiates Coverage On Teva Pharmaceutical Indus With Buy Rating, Announces Price Target of $13

BenzingaDec 18, 2023 08:07 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaDec 18, 2023 08:05 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaNov 27, 2023 05:41 ET

Alvotech Upgraded at Citi Citing FDA Nod for Biosimilars

Seeking AlphaOct 20, 2023 10:25 ET

UBS Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $11

BenzingaSep 20, 2023 09:08 ET